While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...

Taking aspirin on a daily basis protects against the recurrence of colon cancer, a new study found. People who took aspirin every day for three years had a 55% reduced risk of colorectal cancer tumors ...

Exercise really is as good as a drug, a groundbreaking new study found. In a global trial, workouts did better than pricey chemotherapy to prevent colon cancer recurrence. Oncologists gathered at the ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

Imagine popping an over-the-counter pill to remedy a headache. Or taking the same to treat inflammation or arthritis. And all the while, the same common pill is working to cut the risk of colon cancer ...